Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
132M
-
Number of holders
-
213
-
Total 13F shares, excl. options
-
58M
-
Shares change
-
-1.36M
-
Total reported value, excl. options
-
$5.62B
-
Value change
-
-$127M
-
Put/Call ratio
-
0.53
-
Number of buys
-
98
-
Number of sells
-
-104
-
Price
-
$97.00
Significant Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q4 2014
248 filings reported holding ALNY - ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK as of Q4 2014.
ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) has 213 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 58M shares
of 132M outstanding shares and own 44.08% of the company stock.
Largest 10 shareholders include FMR LLC (11.5M shares), WELLINGTON MANAGEMENT GROUP LLP (8.95M shares), VANGUARD GROUP INC (3.72M shares), FRANKLIN RESOURCES INC (2.14M shares), GILDER GAGNON HOWE & CO LLC (1.95M shares), BlackRock Institutional Trust Company, N.A. (1.6M shares), UBS GLOBAL ASSET MANAGEMENT AMERICAS INC (1.6M shares), BlackRock Fund Advisors (1.46M shares), MORGAN STANLEY (1.38M shares), and Falcon Edge Capital LP (1.37M shares).
This table shows the top 213 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.